How Smart, Connected Facilities Are Driving Growth In Biopharma

By Joel Franke

An aging increasing world population heightens the demand for health care products, particularly in emerging markets. The US and Europe are continuing to lead the way, moving from high volume, low variety production to delivery of a wider variety of products in smaller batches at lower costs to meet existing and future demand.

Explore how the global biotechnology sector is maintaining momentum while facing new challenges, reform and regulation changes, the growing need for security against counterfeiting, product sterilization, and the next steps for the industry.